We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Traditional Chinese Medicinal Plant Extract Protects against PD

By LabMedica International staff writers
Posted on 22 Nov 2017
Print article
Image: Glycyrrhiza uralensis (Chinese licorice) is the source of the neuroprotective compound liquiritigenin (Photo courtesy of Wikimedia Commons).
Image: Glycyrrhiza uralensis (Chinese licorice) is the source of the neuroprotective compound liquiritigenin (Photo courtesy of Wikimedia Commons).
A team of Korean neurodegenerative disease researchers has identified a naturally occurring drug that prevents the death of dopamine-producing neurons that characterizes Parkinson's disease.

Parkinson's disease is a degenerative brain disorder caused by the death of dopaminergic neurons in the middle cerebral brain. It is a disease with a higher incidence in the elderly population, exhibiting symptoms such as tremors, stiffness, reduced motor capability, and postural instability.

RNF146 (RING finger protein 146) is an E3 ubiquitin ligase enzyme that specifically recognizes and polyubiquitinates poly (ADP-ribose) (PAR)-conjugated substrates for proteasomal degradation. RNF146 has been shown to be neuroprotective against PAR polymerase-1 (PARP1)-induced cell death during stroke.

To discover the mechanism that underlies the neuroprotective effect of RNF146, a team of Korean investigators used a high-throughput screen based on a luciferase construct harboring the RNF146 promoter to evaluate compounds in the natural materials library of the Natural Medicine Bank of the Korea Foundation.

The investigators reported in the October 11, 2017, online edition of the journal Oncotarget that they had identified the licorice extract liquiritigenin as a potent RNF146 inducer. RNF146 expression and the RNF146 inducer liquiritigenin could prevent cell death elicited by Parkinson’s disease-associated and PARP1-activating stimuli.

The investigators further reported that RNF146 expression by liquiritigenin was mediated by estrogen receptor activation and contributed to cytoprotective effect of liquiritigenin. In addition, RNF146 expression by liquiritigenin in mouse brains provided dopaminergic neuroprotection in a 6-hydroxydopamine Parkinson's disease mouse model.

Contributing author Dr. Yun-Il Lee, a senior researcher at Daegu Gyeongbuk Institute of Science and Technology, said, "Neuronal death is involved in a variety of signaling systems in vivo. Therefore, it is essential to identify a new mechanism that is able to control the system comprehensively and we have found additional possibilities in licorice extract. I would like to contribute to the treatment of degenerative brain diseases such as Parkinson's disease by conducting advanced researches, comprehensive research and clinical studies."

Related Links:
Daegu Gyeongbuk Institute of Science and Technology

Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Chlamydia Trachomatis Assay
Chlamydia Trachomatis IgG
New
Malondialdehyde HPLC Test
Malondialdehyde in Serum/Plasma – HPLC

Print article

Channels

Clinical Chemistry

view channel
Image: A one-step confirmatory laboratory test could definitively diagnose active syphilis infection within 10 minutes (Photo courtesy of Adobe Stock)

First Comprehensive Syphilis Test to Definitively Diagnose Active Infection In 10 Minutes

In the United States, syphilis cases have surged by nearly 80% from 2018 to 2023, with 209,253 cases recorded in the most recent year of data. Syphilis, which can be transmitted sexually or from mother... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.